FOXA1 and liver dysplastic nodule: Mechanistically, FOXA1 binds to the promoter region of SATB1 and inhibits its transcription, leading to the inactivation of the Wnt/β-catenin signaling pathway, thereby inhibiting podocyte apoptosis and DN progression [48].